Bio Green Med Solution BGMS
NASDAQ BGMS
$0.87 +0.04 (+4.52%)
As of: Sep 3, 2026 · 12:24 PM EDT

Bio Green Med Solution (BGMS) Non-Current Assets (2010 - 2026)

Bio Green Med Solution (BGMS) posted quarterly Non-Current Assets of $1.9 million for Q1 2026, up 9610.0% year-over-year from $20000.0 in Q1 2025, and up 0.67% quarter-over-quarter from $1.9 million in Q4 2025.

Analysis

Bio Green Med Solution (BGMS) Non-Current Assets (2010 - 2026) Analysis & Trends

Bio Green Med Solution (BGMS) has reported Non-Current Assets for 17 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Assets rose 9610.0% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $5.6 million (up 302.8% YoY), while the FY2025 annual figure was $1.9 million, up 359.29% from the prior year.
  • Non-Current Assets rose to $1.9 million in Q1 2026 per BGMS's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.8 million in Q2 2022 and bottomed at $18000.0 in Q2 2025.
  • Historically, Non-Current Assets has averaged $1.8 million across 5 years, with a median of $1.7 million in 2023.
  • Annual changes were most pronounced in 2025 — Non-Current Assets plunged 98.5% — and 2026, when it surged 9610.0%.
  • Bio Green Med Solution's Non-Current Assets stood at $3.6 million in 2022, then plunged by 62.6% to $1.4 million in 2023, then slumped by 69.14% to $420000.0 in 2024, then surged by 359.29% to $1.9 million in 2025, then grew by 0.67% to $1.9 million in 2026.
  • Business Quant data shows BGMS's Non-Current Assets at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 141.27 Bn 133.41 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 86.46 Bn 78.47 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 64.96 Bn 59.78 Bn 1.37 Bn 1.96 Bn
4 Moderna 57.22 Bn 52.08 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.67 Bn 44.67 Bn - 294.93 Mn
6 BeOne Medicines 40.40 Bn 35.30 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.14 Bn 27.30 Bn - 18.06 Bn
9 Insmed 27.39 Bn 26.23 Bn 358.27 Mn 468.65 Mn
10 Bio Green Med Solution 4.87 Mn 1.08 Mn 79,000.00 1.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.89 Mn
Mar 31, 2026 1.94 Mn
Dec 31, 2025 1.93 Mn
Sep 30, 2025 1.71 Mn
Jun 30, 2025 18,000.00
Mar 31, 2025 20,000.00
Dec 31, 2024 420,000.00
Sep 30, 2024 468,000.00
Jun 30, 2024 483,000.00
Mar 31, 2024 1.33 Mn
Dec 31, 2023 1.36 Mn
Sep 30, 2023 1.38 Mn
Jun 30, 2023 1.70 Mn
Mar 31, 2023 3.64 Mn
Dec 31, 2022 3.64 Mn
Sep 30, 2022 3.66 Mn
Jun 30, 2022 3.82 Mn
Mar 31, 2022 3.60 Mn
Dec 31, 2021 2.19 Mn
Sep 30, 2021 1.92 Mn